What is Wave Life Sciences Ltd. Ordinary Shares's Market Cap?

Wave Life Sciences Ltd. Ordinary Shares's Market Cap is $947.8M, based on as-reported figures from SEC (XBRL) filings.

What is Wave Life Sciences Ltd. Ordinary Shares's Enterprise Value?

Wave Life Sciences Ltd. Ordinary Shares's Enterprise Value is $579.8M, based on as-reported figures from SEC (XBRL) filings.

What is Wave Life Sciences Ltd. Ordinary Shares's Price / Sales?

Wave Life Sciences Ltd. Ordinary Shares's Price / Sales is 14.5×, based on as-reported figures from SEC (XBRL) filings.

What is Wave Life Sciences Ltd. Ordinary Shares's EV / Revenue?

Wave Life Sciences Ltd. Ordinary Shares's EV / Revenue is 8.9×, based on as-reported figures from SEC (XBRL) filings.

What is Wave Life Sciences Ltd. Ordinary Shares's EV / EBITDA?

Wave Life Sciences Ltd. Ordinary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Wave Life Sciences Ltd. Ordinary Shares's Revenue (TTM)?

Wave Life Sciences Ltd. Ordinary Shares's Revenue (TTM) is $65.4M, based on as-reported figures from SEC (XBRL) filings.

What is Wave Life Sciences Ltd. Ordinary Shares's Net Income (TTM)?

Wave Life Sciences Ltd. Ordinary Shares's Net Income (TTM) is -$202.5M, based on as-reported figures from SEC (XBRL) filings.

What is Wave Life Sciences Ltd. Ordinary Shares's EBITDA?

Wave Life Sciences Ltd. Ordinary Shares's EBITDA is -$214.5M, based on as-reported figures from SEC (XBRL) filings.

What is Wave Life Sciences Ltd. Ordinary Shares's Diluted EPS (TTM)?

Wave Life Sciences Ltd. Ordinary Shares's Diluted EPS (TTM) is -1.03, based on as-reported figures from SEC (XBRL) filings.

What is Wave Life Sciences Ltd. Ordinary Shares's EBITDA Margin?

Wave Life Sciences Ltd. Ordinary Shares's EBITDA Margin is -328.2%, based on as-reported figures from SEC (XBRL) filings.

Wave Life Sciences Ltd. Ordinary Shares (WVE) Financial Statements

Wave Life Sciences Ltd. Ordinary Shares

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00B642V63

XNAS · usd

4.81▼ 0.10 (-2.04%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close4.91

Day's Range4.76 – 4.93

52-Week Range4.65 – 21.73

Volume3.1M

Avg Volume3.4M

Share Statistics

Shares Outstanding

Employees317

ExchangeXNAS

Listed2015-11-11

Share count as of July 23, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Wave Life Sciences Ltd. Ordinary Shares (WVE)

What is Wave Life Sciences Ltd. Ordinary Shares's Market Cap?: Wave Life Sciences Ltd. Ordinary Shares's Market Cap is $947.8M, based on as-reported figures from SEC (XBRL) filings.
What is Wave Life Sciences Ltd. Ordinary Shares's Enterprise Value?: Wave Life Sciences Ltd. Ordinary Shares's Enterprise Value is $579.8M, based on as-reported figures from SEC (XBRL) filings.
What is Wave Life Sciences Ltd. Ordinary Shares's Price / Sales?: Wave Life Sciences Ltd. Ordinary Shares's Price / Sales is 14.5×, based on as-reported figures from SEC (XBRL) filings.
What is Wave Life Sciences Ltd. Ordinary Shares's EV / Revenue?: Wave Life Sciences Ltd. Ordinary Shares's EV / Revenue is 8.9×, based on as-reported figures from SEC (XBRL) filings.
What is Wave Life Sciences Ltd. Ordinary Shares's EV / EBITDA?: Wave Life Sciences Ltd. Ordinary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Wave Life Sciences Ltd. Ordinary Shares's Revenue (TTM)?: Wave Life Sciences Ltd. Ordinary Shares's Revenue (TTM) is $65.4M, based on as-reported figures from SEC (XBRL) filings.
What is Wave Life Sciences Ltd. Ordinary Shares's Net Income (TTM)?: Wave Life Sciences Ltd. Ordinary Shares's Net Income (TTM) is -$202.5M, based on as-reported figures from SEC (XBRL) filings.
What is Wave Life Sciences Ltd. Ordinary Shares's EBITDA?: Wave Life Sciences Ltd. Ordinary Shares's EBITDA is -$214.5M, based on as-reported figures from SEC (XBRL) filings.
What is Wave Life Sciences Ltd. Ordinary Shares's Diluted EPS (TTM)?: Wave Life Sciences Ltd. Ordinary Shares's Diluted EPS (TTM) is -1.03, based on as-reported figures from SEC (XBRL) filings.
What is Wave Life Sciences Ltd. Ordinary Shares's EBITDA Margin?: Wave Life Sciences Ltd. Ordinary Shares's EBITDA Margin is -328.2%, based on as-reported figures from SEC (XBRL) filings.